Pseudomonas Aeruginosa Treatment

Microbion Corporation Announces Orphan Drug Designation Granted for Pravibismane Suspension for Inhalation by US FDA    Fairfield Sun Times

PH marine sediments source of antibiotics — expert » Manila Bulletin News    Manila Bulletin

International Day for Biological Diversity 2020: Why viruses are necessary    Down To Earth Magazine

Gram-Negative Bacterial Infection Market Estimated to Experience a Hike in Growth by 2025    Farmers Ledger

Maintaining a Healthy Upper Respiratory Tract Microbiome May Help Prevent Secondary Infections in Influenza A Patients    P&T Community

Ruxolitinib Plus Post-Transplant Cyclophosphamide Controls GVHD in Myelofibrosis    Targeted Oncology

Light drives injection    EurekAlert

Light drives injection    EurekAlert

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy    The Lancet

Armata Pharmaceuticals Announces First Quarter 2020 Results and Provides General Corporate Update    P&T Community

Phase 1b Study of CB-280 for CF Chronic Lung Infections May Open...    Cystic Fibrosis News Today

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy    The Lancet

Savara to Advance Bronchiectasis Therapy Apulmiq After Deal With...    Bronchiectasis News Today

RedHill Biopharma Receives FDA Approval for COVID-19 Clinical Study with Opaganib in the U.S.    GlobeNewswire

Redhill looks to extend opaganib access following positive COVID-19 study results    BioWorld Online

Erythema multiforme: What we know    dvm360

Sesen Bio Reports Positive Interactions with EMA on Regulatory Pathway for Vicinium®    Business Wire

Antabio Receives QIDP Designation From the US FDA for the Development of MEM-ANT3310, a Novel Broad-Spectrum Combination Therapy Targeting WHO's Priority Pathogens    PRNewswire

Redhill looks to extend opaganib access following positive COVID-19 study results    BioWorld Online

New antibiotic fights drug-resistant bacteria without notable toxic side-effects    News-Medical.Net

New antibiotic fights drug-resistant bacteria without notable toxic side-effects    News-Medical.Net

Venatorx Pharmaceuticals and GARDP Partner to Develop New Antibiotic for Hospital Acquired Infections with Limited Treatment Options    MyChesCo

Venatorx Pharmaceuticals and GARDP Partner to Develop New Antibiotic for Hospital Acquired Infections with Limited Treatment Options    MyChesCo

Venatorx Pharmaceuticals and GARDP Partner to Develop New Antibiotic for Hospital Acquired Infections with Limited Treatment Options    MyChesCo

Venatorx Pharmaceuticals and GARDP Partner to Develop New Antibiotic for Hospital Acquired Infections with Limited Treatment Options    MyChesCo

Venatorx and GARDP collaborate to accelerate development of new antibiotic    News-Medical.Net

Microbial compound in fluconazole formulation used to combat Candida    European Pharmaceutical Review

A widespread toxin−antitoxin system exploiting growth control via alarmone signaling    pnas.org

Armata Pharmaceuticals to Participate in the Maxim Group M-Vest Infectious Disease Virtual Conference: The Renaissance of the Anti-Infective Sector    P&T Community

Venatorx and GARDP collaborate to accelerate development of new antibiotic    News-Medical.Net

Long-Lasting, Low Toxicity Antimicrobial Peptide Fights ‘Superbug’ Lung Infections    Newswise

Antimicrobial peptides: Application informed by evolution    Science Magazine

Antimicrobial peptides: Application informed by evolution    Science Magazine

New antibiotic developed to fight superbugs could be used to treat pneumonia in COVID-19 patients    Daily Mail

Microbial compound in fluconazole formulation used to combat Candida    European Pharmaceutical Review

Thermo Fisher Scientific adds Cefiderocol and Imipenem/Relebactam to manual and automated Antimicrobial Susceptibility Testing Platforms including ARIS HiQ    PRNewswire

Stewardship / Resistance Scan for Apr 27, 2020    CIDRAP

Dysphagia and Chronic Pulmonary Aspiration in Children | American Academy of Pediatrics    AAP News

Long-Lasting, Low Toxicity Antimicrobial Peptide Fights ‘Superbug’ Lung Infections    Newswise

Dysphagia and Chronic Pulmonary Aspiration in Children | American Academy of Pediatrics    AAP News

Chimerix Announces Initiation of a Phase 2/3 Study of DSTAT in Acute Lung Injury for Patients with Severe COVID-19    Yahoo Finance

Venatorx Pharmaceuticals and GARDP Partner to Develop New Antibiotic for Hospital Acquired Infections With Limited Treatment Options    Business Wire

Enhanced therapeutic index of an antimicrobial peptide in mice by increasing safety and activity against multidrug-resistant bacteria    Science Advances

Enhanced therapeutic index of an antimicrobial peptide in mice by increasing safety and activity against multidrug-resistant bacteria    Science Advances

Shionogi Receives European Commission Marketing Authorisation for FETCROJA® (cefiderocol) for the Treatment of Infections Due to Aerobic Gram-negative Bacteria in Adults With Limited Treatment Options    Business Wire

EC approval for Shionogi's Fetcroja    The Pharma Letter

Microbial compound in fluconazole formulation used to combat Candida    European Pharmaceutical Review

Stewardship / Resistance Scan for Apr 27, 2020    CIDRAP

Shionogi Receives European Commission Marketing Authorisation for FETCROJA® (cefiderocol) for the Treatment of Infections Due to Aerobic Gram-negative Bacteria in Adults With Limited Treatment Options | Small Molecules | News Channels    PipelineReview.com

Shionogi Receives European Commission Marketing Authorisation for FETCROJA® (cefiderocol) for the Treatment of Infections Due to Aerobic Gram-negative Bacteria in Adults With Limited Treatment Options    Business Wire

Thermo Fisher Scientific adds Cefiderocol and Imipenem/Relebactam to manual and automated Antimicrobial Susceptibility Testing Platforms including ARIS HiQ    PRNewswire

Activists seek testing of Ganga water for COVID-19 treatment    The Hindu

Microbial compound in fluconazole formulation used to combat Candida    European Pharmaceutical Review

Mineral Independent    Clark Fork Valley Press

Shionogi Receives European Commission Marketing Authorisation for FETCROJA® (cefiderocol) for the Treatment of Infections Due to Aerobic Gram-negative Bacteria in Adults With Limited Treatment Options    Business Wire

EC approval for Shionogi's Fetcroja    The Pharma Letter

Activists seek testing of Ganga water for COVID-19 treatment    The Hindu

Microbial compound in fluconazole formulation used to combat Candida    European Pharmaceutical Review

Venatorx Pharmaceuticals and GARDP Partner to Develop New Antibiotic for Hospital Acquired Infections With Limited Treatment Options    Kankakee Daily Journal

Evolution of bacterial movement revealed    Phys.org

Venatorx and GARDP collaborate to accelerate development of new antibiotic    News-Medical.Net

Thermo Fisher Scientific adds Cefiderocol and Imipenem/Relebactam to manual and automated Antimicrobial Susceptibility Testing Platforms including ARIS HiQ    PRNewswire

Armata Pharmaceuticals to Participate in the Maxim Group M-Vest Infectious Disease Virtual Conference: The Renaissance of the Anti-Infective Sector    P&T Community

Activists seek testing of Ganga water for COVID-19 treatment    The Hindu

Antimicrobial peptides: Application informed by evolution    Science Magazine

Venatorx Pharmaceuticals and GARDP Partner to Develop New Antibiotic for Hospital Acquired Infections With Limited Treatment Options    Kankakee Daily Journal

Shionogi Receives European Commission Marketing Authorisation for FETCROJA® (cefiderocol) for the Treatment of Infections Due to Aerobic Gram-negative Bacteria in Adults With Limited Treatment Options    Business Wire

The Love for our Work    Psychiatric Times

Venatorx Pharmaceuticals and GARDP Partner to Develop New Antibiotic for Hospital Acquired Infections With Limited Treatment Options    BioSpace

Antimicrobial peptides: Application informed by evolution    Science Magazine

Upregulation of virulence genes promotes Vibrio cholerae biofilm hyperinfectivity    pnas.org

Chimerix Announces Initiation of a Phase 2/3 Study of DSTAT in Acute Lung Injury for Patients with Severe COVID-19    Yahoo Finance

Venatorx Pharmaceuticals and GARDP Partner to Develop New Antibiotic for Hospital Acquired Infections With Limited Treatment Options    BioSpace

Microbial compound in fluconazole formulation used to combat Candida    European Pharmaceutical Review

Polyphor announces financial results for the full-year 2019    PharmiWeb.com

Global Antibiotic Resistance Market 2020: Various Services, Segmentation, Growing Trends, Competitive Landscape and Opportunities till 2025    Latest Herald

Thermo Fisher Scientific adds Cefiderocol and Imipenem/Relebactam to manual and automated Antimicrobial Susceptibility Testing Platforms including ARIS HiQ    PRNewswire

Thermo Fisher Scientific adds Cefiderocol and Imipenem/Relebactam to manual and automated Antimicrobial Susceptibility Testing Platforms including ARIS HiQ    PRNewswire

Stewardship / Resistance Scan for Apr 27, 2020    CIDRAP